| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/09/2009 | US20090092581 Interferons of rhesus and cynomolgus origin and uses thereof |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | DE19543553B4 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 04/09/2009 | CA2699951A1 Methods for drying bacteriophage and bacteriophage-containing compositions, the resulting dry compositions, and methods of use |
| 04/09/2009 | CA2699451A1 Bacteriophage with enhanced lytic activity |
| 04/08/2009 | EP2045323A1 Linear expression constructs for production of influenza virus particles |
| 04/08/2009 | EP2044953A1 Viral antigens |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044948A1 Methods and compositions concerning poxviruses and cancer |
| 04/08/2009 | EP2044947A1 Compositions and methods |
| 04/08/2009 | EP2044224A2 Chimeric virus-like particles |
| 04/08/2009 | EP2044198A2 Chimeric influenza virus-like particles |
| 04/08/2009 | EP2043680A1 Method of immunisation against the four serotypes of dengue |
| 04/08/2009 | EP1539808B1 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/08/2009 | EP1501921B1 Improved viral purification methods |
| 04/08/2009 | CN101405389A Novel protein expression system |
| 04/08/2009 | CN101405033A Enhanced production of infectious parvovirus vectors in insect cells |
| 04/08/2009 | CN101402945A Process for producing small RNA recombinant birds adeno-associated virus for expression of infectivity resistant bursa of fabricius disease virus |
| 04/08/2009 | CN101402944A EV-71 virus seed, inactivated vaccine for human and method of producing the same |
| 04/08/2009 | CN100475966C New-type adenovirus with tumor cell specific infection and transgenic expression capability |
| 04/08/2009 | CN100475842C Molecular structure of RHD negative genes locus |
| 04/07/2009 | US7514252 Tumor/cancer therapy/drugs for infecting/killing cells with mutant virus; comprises deletion or inactivating mutation in both copies of gene, at least one copy is reintroduced under transcriptional control of cell-specific and/or tumor-specific promoter; capable of delivering transgene cytotoxic to tumor |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2264488C A method for generating birnavirus from synthetic rna transcripts |
| 04/07/2009 | CA2208519C Viral vector complexes having adapters of predefined valence |
| 04/02/2009 | WO2009042202A2 Formulations for preservation of rota virus |
| 04/02/2009 | WO2009041831A1 PHAGE ϕMRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF |
| 04/02/2009 | WO2008057550A3 Stabilization of vaccines by lyophilization |
| 04/02/2009 | WO2005081716A3 DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) |
| 04/02/2009 | US20090088398 Recombinant adenoviral vectors and methods of use |
| 04/02/2009 | US20090087831 Methods for evaluating a bacteriophage preparation |
| 04/02/2009 | US20090087448 Stable Immunoprophylactic and Therapeutic Compositions Derived From Transgenic Plant Cells and Methods for Production |
| 04/02/2009 | CA2700164A1 Phage .phi.mru polynucleotides and polypeptides and uses thereof |
| 04/01/2009 | EP2042512A2 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 04/01/2009 | EP2041323A1 Virosomes, methods of preparation, and immunogenic compositions |
| 04/01/2009 | EP2041321A2 Viral inhibitory nucleotide sequences and vaccines |
| 04/01/2009 | EP2041273A1 Method for influenza virus purification |
| 04/01/2009 | EP1880006B1 Primate t-lymphotropic viruses |
| 04/01/2009 | EP1439856B1 Recombinant rabies vaccine and methods of preparation and use |
| 04/01/2009 | CN101400795A Chimeric tymovirus-like particles |
| 04/01/2009 | CN101400366A Hepatitis c virus non structural fusion protein |
| 04/01/2009 | CN101397572A Method for rescuing influenza virus and bidirectional transcription vector special therefor |
| 04/01/2009 | CN100473721C Pneumovirus NS proteins antagonising interferon (IFN) response |
| 03/31/2009 | US7510875 Methods for producing purified adenoviral vectors |
| 03/31/2009 | US7510872 Transgenic cell comprising adenoviral vector for use as gene delivery tool; tissue engineering heterologous gene expression; DNA vaccines |
| 03/31/2009 | US7510868 Chimeric adenoviruses for use in cancer treatment |
| 03/31/2009 | US7510863 Nucleotide sequence coding single stranded RNA viral sequences for use in generation antibodies to prevent, treat and diagnose respiratory system disorders in poultry; veterinary medicine |
| 03/31/2009 | US7510862 Nucleic acid comprising retroviral sequences for use as tools in generation of vaccines for prevention of viral diseases and infection; immunotherapy; viricides, antisense agents |
| 03/26/2009 | WO2009037402A2 Hpiv-2 variants and medical applications thereof |
| 03/26/2009 | WO2009036933A2 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 03/26/2009 | WO2009012155A3 Preparation of negative-stranded rna viruses by electroporation |
| 03/26/2009 | WO2008147496A3 Neuraminidase-deficient live influenza vaccines |
| 03/26/2009 | WO2008140557A3 A method of predicting influenza outbreaks |
| 03/26/2009 | WO2004096993A3 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 03/26/2009 | US20090082289 Adenoviral vectors having a protein IX deletion |
| 03/26/2009 | US20090081785 Desiccated Biologics And Methods Of Preparing The Same |
| 03/26/2009 | US20090081728 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences |
| 03/26/2009 | US20090081667 Viral Variants With Altered Susceptibility To Nucleoside Analogs And Uses Thereof |
| 03/26/2009 | US20090081637 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 03/26/2009 | US20090081252 Decreasing potential iatrogenic risks associated with influenza vaccines |
| 03/26/2009 | US20090081251 Production of Viral Vaccines in Suspension on Avian Embryonic Derived Stem Cell Lines |
| 03/26/2009 | US20090081202 Immunogenic compositions and methods |
| 03/26/2009 | US20090081193 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 03/26/2009 | US20090081173 Methods and compositions involving bacteriophage isolates |
| 03/26/2009 | US20090081161 Treatment of neoplasms with viruses |
| 03/26/2009 | CA2699638A1 Down-regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 03/26/2009 | CA2694494A1 Hpiv-2 variants and medical applications thereof |
| 03/25/2009 | EP2039773A1 Mutant vesicular stomatitis viruses and use thereof |
| 03/25/2009 | EP2039766A1 Immunocompetent cell having anti-cd38 antibody on its cell surface |
| 03/25/2009 | EP2039761A1 Influenza vaccine composition |
| 03/25/2009 | EP2039368A2 Methods for preventing reactivation of latent virus and controlling virus replication |
| 03/25/2009 | EP2037943A2 Treatment of connective tissue disorders |
| 03/25/2009 | EP1250593B1 IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs) |
| 03/25/2009 | CN101395477A Method for determining the concentration of virus particles/virus antigens |
| 03/25/2009 | CN101395175A Chicken virus vaccine and diagnostic |
| 03/25/2009 | CN101392267A Therapeutic effects of Math1 gene pairs forsensorineural hearing loss |
| 03/25/2009 | CN101392239A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 03/25/2009 | CN101392027A Fusion protein for treating alzheimer's disease and preparation method thereof |
| 03/25/2009 | CN100471957C Adenovirus vectors for immunotherapy |
| 03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
| 03/24/2009 | US7507571 Listeria monocytogenes bacteriophage and uses thereof |
| 03/24/2009 | US7507415 West nile virus vaccine |
| 03/24/2009 | CA2407894C Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 03/19/2009 | WO2009035420A1 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 03/19/2009 | WO2009035412A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 03/19/2009 | WO2009033276A1 Malva mosaic virus and virus-like particles and uses thereof |
| 03/19/2009 | WO2009006618A3 Herpes simplex virus mutant icp0 protein |
| 03/19/2009 | WO2008156681A3 Adenoviral vectors for influenza virus production |
| 03/19/2009 | WO2008118592A3 Use of an avirulent bordetella mutant as a live vaccine vector |
| 03/19/2009 | WO2008079539A3 Recombinant herpesvirus with diminished latency and methods of using same |
| 03/19/2009 | US20090075357 Production of recombinant aav virions |
| 03/19/2009 | US20090074812 Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
| 03/19/2009 | US20090074804 Vero cell-based influenza virus strains and vaccines |
| 03/19/2009 | US20090074726 Mva expressing modified hiv envelope, gag, and pol genes |
| 03/19/2009 | US20090074658 Compositions and methods for generating and screening adenoviral libraries |
| 03/19/2009 | CA2699093A1 Malva mosaic virus and virus-like particles and uses thereof |
| 03/18/2009 | EP2036980A1 Down regulation of gene expression using virus-like particles charged with nucleic acid |
| 03/18/2009 | EP1283887B1 Chimeric arterivirus-like particles |
| 03/18/2009 | EP1200612B1 Dna encoding a plant deoxyhypusine synthase, transgenic plants and a method for controlling senescence and programmed cell death in plants |